Other substances

Silodosin

An alpha-1 adrenoreceptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Silodosin on PubChem

Marketed as

RAPAFLO; RAPILIF; SILODOSIN; SILODYX; URIEF; UROREC

 

Structure image - Silodosin

C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F

Supporting references

Link Tested on Impact factor Notes Publication date
High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein
Spike protein Small molecule In silico 		in silico 3.22

Predicted to bind the SARS-CoV-2 spike protein RBD S1 at the interface with the host ACE2 receptor.

 Oct/25/2020

AI-suggested references

Link Publication date
The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19.
Mar/31/2021
Export (.csv)